| |
| |
|
| Insider
Information: |
Cole Hugh M |
| Relationship: |
Chief Operating Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
115,144 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$206,954 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
115,144 |
|
|
| Total
Value |
$206,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 218.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP, Chief Business Of... |
2016-03-16 |
5,062 |
2016-03-16 |
0 |
Premium* |
|
|
Jounce Therapeutics Inc |
JNCE |
Chief Operating Officer |
2023-01-10 |
110,082 |
2018-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JNCE |
Jounce Therapeutics Inc |
Chief Operating Officer |
• – – |
2023-01-10 |
4 |
S |
$1.12 |
$10,284 |
D/D |
(9,182) |
110,082 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Operating Officer |
• – – |
2023-01-09 |
4 |
S |
$1.10 |
$8,197 |
D/D |
(7,452) |
119,264 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
126,716 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
42,500 |
106,716 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2022-01-10 |
4 |
S |
$6.65 |
$41,263 |
D/D |
(6,205) |
64,216 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2022-01-07 |
4 |
S |
$7.30 |
$25,316 |
D/D |
(3,468) |
70,421 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,700 |
73,889 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2021-01-22 |
4 |
AS |
$11.95 |
$215,100 |
D/D |
(18,000) |
47,189 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2021-01-22 |
4 |
OE |
$4.40 |
$54,750 |
D/D |
10,000 |
65,189 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2021-01-08 |
4 |
S |
$7.00 |
$23,380 |
D/D |
(3,340) |
55,189 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2021-01-07 |
4 |
S |
$6.76 |
$19,462 |
D/D |
(2,879) |
58,529 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2020-08-18 |
4 |
S |
$4.71 |
$3,504 |
D/D |
(744) |
61,408 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2020-08-17 |
4 |
S |
$4.86 |
$2,206 |
D/D |
(454) |
62,152 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2020-08-14 |
4 |
S |
$4.64 |
$4,566 |
D/D |
(984) |
62,606 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
63,590 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2020-01-07 |
4 |
S |
$7.78 |
$20,415 |
D/D |
(2,624) |
33,590 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2019-08-16 |
4 |
S |
$3.92 |
$3,991 |
D/D |
(1,018) |
36,214 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2019-08-15 |
4 |
S |
$4.00 |
$2,592 |
D/D |
(648) |
37,232 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2019-08-14 |
4 |
S |
$4.10 |
$2,747 |
D/D |
(670) |
37,880 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2019-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,250 |
38,550 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
16,300 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Business Officer |
• – – |
2018-06-15 |
4 |
B |
$7.84 |
$14,896 |
D/D |
1,900 |
1,900 |
2.74 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2016-03-16 |
4 |
D |
$6.21 |
$15,140 |
D/D |
(2,438) |
5,062 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2016-03-16 |
4 |
OE |
$6.21 |
$46,575 |
D/D |
7,500 |
7,500 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
